Neuren Pharmaceuticals
NEU.AX
#5533
Rank
C$2.06 B
Marketcap
C$16.25
Share price
36.07%
Change (1 day)
28.01%
Change (1 year)

Earnings for Neuren Pharmaceuticals (NEU.AX)

Earnings in 2025: C$37.04 Million

According to Neuren Pharmaceuticals's latest financial reports the company's current earnings are C$43.29 Million. In 2025 the company made an earning of C$37.04 Million a decrease over its 2024 earnings that were of C$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neuren Pharmaceuticals from 2002 to 2025

Annual earnings

Year Earnings Change
2025C$37.04 M-77.09%
2024C$0.16 B-18.58%
2023C$0.19 B111519.63%
2022C$0.17 M-102.22%
2021-C$8.03 Million-20.06%
2020-C$10.05 Million-6.65%
2019-C$10.77 Million-449.8%
2018C$3.07 M-213.69%
2017-C$2.71 Million-80.94%
2016-C$14.2 Million-3.07%
2015-C$14.65 Million51.42%
2014-C$9.68 Million-32.7%
2013-C$14.37 Million87.47%
2012-C$7.67 Million10.96%
2011-C$6.91 Million-4.11%
2010-C$7.21 Million21025.61%
2009-C$0.04 Million-99.78%
2008-C$15.4 Million1.99%
2007-C$15.1 Million33.24%
2006-C$11.34 Million31.45%
2005-C$8.62 Million37.67%
2004-C$6.27 Million4.98%
2003-C$5.97 Million36.5%
2002-C$4.37 Million